Capricor Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CAPR Nasdaq 2834 www.capricor.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Capricor Therapeutics, Inc.

How Recent Developments Are Rewriting the Story for Capricor Therapeutics - Dec 6th, 2025 3:08 am
CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know - Dec 5th, 2025 8:34 am
Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock - Dec 5th, 2025 4:15 am
Capricor Therapeutics Announces Proposed Public Offering of Common Stock - Dec 4th, 2025 2:01 pm
Trending tickers: Salesforce, Microsoft, Netflix, Capricor Therapeutics and Vodafone - Dec 4th, 2025 2:32 am
Capricor Therapeutics (CAPR) Valuation After Positive Phase 3 HOPE-3 Results for DMD Therapy Deramiocel - Dec 3rd, 2025 7:08 pm
Sector Update: Health Care Stocks Higher Late Afternoon - Dec 3rd, 2025 1:50 pm
Top Midday Gainers - Dec 3rd, 2025 12:12 pm
Sector Update: Health Care Stocks Higher Wednesday Afternoon - Dec 3rd, 2025 11:35 am
Top Midday Stories: Microsoft Lowers AI Software Sales Quotas; Marvell to Acquire Celestial AI for $3.25 Billion - Dec 3rd, 2025 9:42 am
Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy - Dec 3rd, 2025 5:20 am
Capricor soars on positive results for Duchenne cell therapy - Dec 3rd, 2025 4:10 am
Can Capricor Therapeutics' (CAPR) Exosome Advancement Shift the Conversation on Its Innovation Pipeline? - Nov 25th, 2025 4:18 pm
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025 - Nov 24th, 2025 7:00 am
Capricor Therapeutics Inc (CAPR) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Nov 10th, 2025 10:00 pm
Capricor: Q3 Earnings Snapshot - Nov 10th, 2025 2:50 pm
Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 10th, 2025 2:01 pm
CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates - Nov 4th, 2025 4:05 pm
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel - Nov 3rd, 2025 7:15 am
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 - Oct 31st, 2025 7:15 am